JP2008523006A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008523006A5 JP2008523006A5 JP2007544807A JP2007544807A JP2008523006A5 JP 2008523006 A5 JP2008523006 A5 JP 2008523006A5 JP 2007544807 A JP2007544807 A JP 2007544807A JP 2007544807 A JP2007544807 A JP 2007544807A JP 2008523006 A5 JP2008523006 A5 JP 2008523006A5
- Authority
- JP
- Japan
- Prior art keywords
- inden
- dihydro
- oxy
- alkyl
- pyrrolidinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0426828A GB0426828D0 (en) | 2004-12-07 | 2004-12-07 | Novel compounds |
| GB0519089A GB0519089D0 (en) | 2005-09-19 | 2005-09-19 | Novel compounds |
| PCT/EP2005/013070 WO2006061193A1 (en) | 2004-12-07 | 2005-12-05 | Indenyl derivatives and use thereof for the treatment of neurological disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008523006A JP2008523006A (ja) | 2008-07-03 |
| JP2008523006A5 true JP2008523006A5 (enExample) | 2009-01-29 |
Family
ID=36121490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007544807A Withdrawn JP2008523006A (ja) | 2004-12-07 | 2005-12-05 | インデニル誘導体および神経学的障害の治療のためのそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090306052A1 (enExample) |
| EP (1) | EP1833796A1 (enExample) |
| JP (1) | JP2008523006A (enExample) |
| KR (1) | KR20070091007A (enExample) |
| AU (1) | AU2005313550A1 (enExample) |
| BR (1) | BRPI0518841A2 (enExample) |
| CA (1) | CA2589831A1 (enExample) |
| IL (1) | IL183656A0 (enExample) |
| MA (1) | MA29084B1 (enExample) |
| MX (1) | MX2007006754A (enExample) |
| NO (1) | NO20073113L (enExample) |
| RU (1) | RU2007125648A (enExample) |
| WO (1) | WO2006061193A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0513886D0 (en) | 2005-07-06 | 2005-08-10 | Glaxo Group Ltd | Novel compounds |
| US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
| US8829041B2 (en) | 2006-06-23 | 2014-09-09 | Abbvie Inc. | Cyclopropyl amine derivatives |
| AU2008321823B2 (en) | 2007-11-13 | 2013-03-07 | Taisho Pharmaceutical Co., Ltd. | Phenylpyrazole derivatives |
| TW201039822A (en) | 2009-02-06 | 2010-11-16 | Taisho Pharmaceutical Co Ltd | Dihydroquinolinone derivatives |
| US9186353B2 (en) * | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
| WO2012037258A1 (en) | 2010-09-16 | 2012-03-22 | Abbott Laboratories | Processes for preparing 1,2-substituted cyclopropyl derivatives |
| US9284324B2 (en) | 2011-12-08 | 2016-03-15 | Taisho Pharmaceutical Co., Ltd | Phenylpyrrole derivative |
| TW201343636A (zh) | 2011-12-27 | 2013-11-01 | 大正製藥股份有限公司 | 苯基三唑衍生物 |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| EP2647377A1 (en) | 2012-04-06 | 2013-10-09 | Sanofi | Use of an h3 receptor antagonist for the treatment of alzheimer's disease |
| WO2023283425A1 (en) | 2021-07-09 | 2023-01-12 | Plexium, Inc. | Aryl compounds and pharmaceutical compositions that modulate ikzf2 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1545673A1 (de) * | 1965-05-13 | 1969-08-28 | Albert Ag Chem Werke | Verfahren zur Herstellung von pharmazeutisch wirksamen Derivaten des 2-Aminoindans |
| US3943149A (en) * | 1972-11-10 | 1976-03-09 | E. R. Squibb & Sons, Inc. | Naphthyloxy acetic acids and related compounds |
| WO1987002035A1 (en) * | 1985-10-04 | 1987-04-09 | Maggioni-Winthrop S.P.A. | Fused cycloaliphatic aminoalcohols |
| AU7513494A (en) * | 1993-08-06 | 1995-02-28 | Upjohn Company, The | 2-aminoindans as selective dopamine d3 ligands |
| AU2004220112A1 (en) * | 2003-03-07 | 2004-09-23 | Eli Lilly And Company | 6-substituted nicotinamide derivatives as opioid receptor antagonists |
-
2005
- 2005-12-05 AU AU2005313550A patent/AU2005313550A1/en not_active Abandoned
- 2005-12-05 CA CA002589831A patent/CA2589831A1/en not_active Abandoned
- 2005-12-05 KR KR1020077015530A patent/KR20070091007A/ko not_active Withdrawn
- 2005-12-05 BR BRPI0518841-5A patent/BRPI0518841A2/pt not_active Application Discontinuation
- 2005-12-05 RU RU2007125648/04A patent/RU2007125648A/ru not_active Application Discontinuation
- 2005-12-05 JP JP2007544807A patent/JP2008523006A/ja not_active Withdrawn
- 2005-12-05 US US11/720,950 patent/US20090306052A1/en not_active Abandoned
- 2005-12-05 EP EP05811338A patent/EP1833796A1/en not_active Withdrawn
- 2005-12-05 WO PCT/EP2005/013070 patent/WO2006061193A1/en not_active Ceased
- 2005-12-05 MX MX2007006754A patent/MX2007006754A/es unknown
-
2007
- 2007-06-04 IL IL183656A patent/IL183656A0/en unknown
- 2007-06-06 MA MA29968A patent/MA29084B1/fr unknown
- 2007-06-18 NO NO20073113A patent/NO20073113L/no not_active Application Discontinuation